Giles A R, Hoogendoorn H, Benford K
Department of Pathology, Queen's University, Kingston, Ontario, Canada.
Br J Haematol. 1987 Nov;67(3):349-53. doi: 10.1111/j.1365-2141.1987.tb02356.x.
Type IIb von Willebrand's disease has been found to be associated with the development of thrombocytopenia following the infusion of DDAVP (desmopressin). It has also been associated with sporadic thrombocytopenia and evidence of spontaneous platelet aggregation. A family with documented Type IIb von Willebrand's disease is described, where two of the affected females presented with moderate to severe thrombocytopenia developing during pregnancy with reversal to normal or minimally reduced platelet counts in the early post gestational period. In each case, the levels of factor VIII:C, von Willebrand factor antigen and von Willebrand factor ristocetin co-factor activity rose during pregnancy but there were notable discrepancies between the levels of each in any one individual. It is suggested that pregnancy resulted in increased synthesis of the variant form of von Willebrand factor resulting in progressively increasing platelet/variant form von Willebrand factor interaction and subsequent thrombocytopenia. Whether this reflects consumption or sequestration remains uncertain. Although spontaneous platelet aggregation was observed in some family members, the majority did not exhibit this phenomenon. Circulating platelet aggregates could not be detected. Both pregnancies were relatively uneventful and there is no history of unusual bleeding associated with pregnancy in the family. These observations suggest that Type IIb von Willebrand's disease should be considered in the differential diagnosis of thrombocytopenia developing during pregnancy, particularly in those individuals where evidence supporting the diagnosis of immune mediated thrombocytopenia is not forthcoming. Where the diagnosis of Type IIb von Willebrand's disease is established, active intervention other than confinement in a hospital with experience in haemostatic disorders is probably not required as the development of thrombocytopenia does not appear to exert an additive effect on the underlying defect relating to the variant form of von Willebrand's disease.
已发现IIb型血管性血友病与输注去氨加压素(DDAVP)后血小板减少症的发生有关。它还与散发性血小板减少症及自发血小板聚集的证据有关。本文描述了一个有记录的IIb型血管性血友病家族,其中两名受影响的女性在孕期出现中度至重度血小板减少,在产后早期血小板计数恢复正常或仅略有降低。在每种情况下,凝血因子VIII:C、血管性血友病因子抗原和血管性血友病因子瑞斯托霉素辅因子活性在孕期均升高,但在任何一个个体中,每种因子的水平之间存在显著差异。提示妊娠导致血管性血友病因子变异形式的合成增加,从而导致血小板/血管性血友病因子变异形式的相互作用逐渐增加,随后出现血小板减少症。这是反映消耗还是隔离尚不确定。虽然在一些家庭成员中观察到自发血小板聚集,但大多数人未表现出这种现象。未检测到循环血小板聚集体。两次妊娠过程相对平稳,家族中无与妊娠相关的异常出血史。这些观察结果表明,在孕期发生血小板减少症的鉴别诊断中应考虑IIb型血管性血友病,特别是在那些没有支持免疫介导性血小板减少症诊断证据的个体中。如果确诊为IIb型血管性血友病,除了在有止血障碍治疗经验的医院进行住院治疗外,可能不需要进行积极干预,因为血小板减少症的发生似乎不会对与血管性血友病因子变异形式相关的潜在缺陷产生叠加影响。